Publications

Chapters, Manuals and Guidelines

• CDC Guidelines for the Control of Pertussis Outbreaks
• Pink Book's Chapter on Pertussis
  Epidemiology & Prevention of Vaccine-Preventable Diseases textbook.
• Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis: 2005 CDC Guidelines
  MMWR 2005;54(RR14):1-16
• Travelers' Health: Yellow Book — Chapter on Pertussis
  CDC's Health Information for International Travel 2010 (Prevention of Specific Infectious Diseases).
• Surveillance Manual's Chapter on Pertussis
  Manual from the Surveillance of Vaccine-Preventable Diseases textbook.

Articles

Vaccine Recommendations and Licensures

• CDC. Updated Recommendation for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Adults 65 Years and Older – Advisory Committee on Immunization Practices (ACIP), 2012. MMWR 2012;61(25):468-70.
• CDC. ACIP provisional recommendations for adults aged 65 years and older on use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) and guidance on use of Tdap products for adults aged 65 years and older. Accessed 3/22/2012.
• CDC. Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2011;60(RR07):1-45.
• CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged Less than 12 Months — Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. 2011;60(41):1424-6.
• CDC. FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR. 2011;60(37):1279-80.
• CDC. Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR 2011;60(01):13-15.
• Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  MMWR May 30, 2008;57(04):1-47, 51
• Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines.
  MMWR December 15, 2006; 55(RR17):1-33
• Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines.
  MMWR March 24 2006;55(RR03):1-34
• Notice to Readers: FDA Approval of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, (INFANRIX®) for Fifth Consecutive DTaP Vaccine Dose
  MMWR September 26, 2003;52(38);921
• Notice to Readers: FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, (PEDIARIX™) for Use in Infants
  MMWR March 14, 2003;52(10);203-204
• Notice to Readers: Food and Drug Administration Approval of a Fifth Acellular Pertussis Vaccine for Use Among Infants and Young Children -- United States, 2002
  MMWR July 5, 2002;51(26);574
• Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
  MMWR November 17, 2000; 49(RR13);1-8
• Combination Vaccines for Childhood Immunization
  MMWR May 14, 1999;48(RR05);1-15
• Notice to Readers FDA Approval of a Fourth Acellular Pertussis Vaccine for Use Among Infants and Young Children
  MMWR November 06, 1998;47(43);934-6
• Pertussis Vaccination: Use of Acellular Pertussis Vaccines Among Infants and Young Children Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  MMWR March 28, 1997; 46(RR-7);1-25
• Diphtheria, Tetanus, and Pertussis: Recommendations for Vaccine Use and Other Preventive Measures Recommendations of the Immunization Practices Advisory Committee (ACIP)
  MMWR August 08, 1991; 40(RR10);1-28

Top of Page

Surveillance, Epidemiology and Outbreaks

• Pertussis Epidemic — Washington, 2012
  MMWR. July 20, 2012; 61(28):517-22
• Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol. Epub ahead of print. Apr 2012.
• Mandal S, Tatti KM, Woods-Stout D, Cassiday PK, Faulkner AE, Griffith MM, Jackson ML, Pawloski LC, Wagner B, Barnes M, Cohn AC, Gershman KA, Messonnier NE, Clark TA, Tondella ML, Martin SW. Pertussis pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA from clinic surfaces. Pediatrics.  2012;129:e424-30.
• Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW. Early impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med. 2012;166:344-9.
• Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine. 2010;28:8001-7.
• Tetanus and pertussis vaccination coverage among adults aged ≥18 years -- United States, 1999 and 2008
  MMWR October 15, 2010;59(40):1302-6
• Wei S, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, Tondella M. Lucia, Martin S. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine (Tdap) against pertussis. Clin Infect Dis. 2010;51:315-21.
• Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007
  MMWR July 25, 2008;57(29):796-9
• Hospital-acquired pertussis among newborns --- Texas, 2004
  MMWR June 6, 2008;57(22):600-3
• Cassiday P, Tobin-D'Angelo M, Watson J, Wu KH, Park M, Sanden G. Co-infection with two different strains of Bordetella pertussis in an infant. J Med Microbiol. 2008;57:388.
• Outbreaks of Respiratory Illness Mistakenly Attributed to Pertussis --- New Hampshire, Massachusetts, and Tennessee, 2004--2006
  MMWR August 24, 2007; 56(33):837-842
• Pertussis outbreak in an Amish community --- Kent County, Delaware, September 2004--February 2005
  MMWR August 4, 2006;55(30):817-21
• Pertussis — United States, 2001-2003
  MMWR December 23, 2005;54(50):1283-86
• Outbreaks of pertussis associated with hospitals-Kentucky, Pennsylvania, and Oregon, 2003
  MMWR January 28, 2005;54(3):67-71
• School-associated pertussis outbreak-Yavapai County, Arizona, September 2002-February 2003
  MMWR March 19, 2004;53(10):216-9
• Fatal case of unsuspected pertussis diagnosed from a blood culture--Minnesota, 2003
  MMWR February 20, 2004;53(6):131-2
• Pertussis outbreak among adults at an oil refinery---Illinois, August--October 2002
  MMWR January 10, 2003;52(01):1-4
• Brennan M, Strebel P, George H, Yih W, Tachdjian R, Lett S, Cassiday P, Sanden G, Wharton M. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis. 1999;181:210-5
• Provisional cases of selected notifiable diseases preventable by vaccination, United States, weeks ending December 19, 1998 and December 13, 1997 (50th Week)
  MMWR December 25, 1998;47(50):1101-6
• Case Definitions for Infectious Conditions Under Public Health Surveillance.
  MMWR May 2, 1997;46(RR10):1-55

Top of Page

Laboratory

• Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM. Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerg Infect Dis. Epub ahead of print. June 2012.
• Pawloski LC, Kirkland KB, Baughman AL, Martin MD, Talbot EA, Messonnier NE, Tondella ML. Does Tdap vaccination interfere with serodiagnosis of pertussis infection? Clin Vaccine Immunol. Epub ahead of print. May 2012.
• Mandal S, Tatti KM, Woods-Stout D, Cassiday PK, Faulkner AE, Griffith MM, Jackson ML, Pawloski LC, Wagner B, Barnes M, Cohn AC, Gershman KA, Messonnier NE, Clark TA, Tondella ML, Martin SW. Pertussis pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA from clinic surfaces. Pediatrics. 2012;129:e424-30.
• Kapasi a, Meade bd, Plikaytis b, Pawloski l, Martin md, Yoder s, Rock mt, Coddens s, Haezebroeck v, Fievet-Groyne f, Bixler g, Jones c, Hildreth s, Edwards km, Messonnier ne, Tondella ML.  Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG Anti-PT ELISAs.  Clin Vaccine Immunol. 2012;19:64-72.
• Tatti Km, Sparks KN, Boney ko, Tondella ML  Novel multi-target real-time PCR assay for the rapid diagnosis of Bordetella species in clinical specimens.  J Clin Microbiol. 2011;49:4059-66.
• Bolt f, Cassiday P, Tondella ML, Dezoysa a, Efstratiou a, Sing a, zasada a, Bernard k, Guiso n, Badell e, Rosso ml, Baldwin a, Dowson c.  Multilocus sequence typing identifies evidence for recombination and two distinct lineages of Corynebacterium diphtheriae.  J Clin Microbiol. 2010;48:4177-85.
• Hall AJ, Cassiday PK, Bernard KA, Bolt F, Steigerwalt AG, Bixler D, Pawloski LC, Whitney AM, Iwaki M, Baldwin A, Dowson CG, Komiya T, Takahashi M, Hinrikson HP, Tondella ML. Novel Corynebacterium diphtheriae in domestic cats. Emerg Infect Dis. 2010;16:688-91.
• Menzies SL, Kadwad V, Pawloski LC, Lin T, Baughman AL, Martin M, Tondella ML, Meade BD, Pertussis Assay Working Group. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin Vaccine Immunol. 2009;16:1781-88.
• Tondella ML, Carlone G, Messonnier N, Quinn C, Meade B, Burns D, Cherry J, Guiso N, Hewlett E, Edwards K, Xing D, Giammanco A, Wirsing von Konig C, Han L, Hueston L, Robbins J, Powell M, Mink C, Poolman J, Hildreth S, Lynn F, Morris A. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine. 2009;27:803-14.
• Tatti K, Wu KH, Tondella ML, Cassiday P, Cortese M, Wilkins P, Sanden G. Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp (253 KB, 9 pages). Diagn Micr Infec Dis. 2008;61:264-72.
• Tatti K, Slade B, Patel M, Messonnier N, Jackson T, Kirkland K, Talbot E, Tondella ML. Real-time polymerase chain reaction detection of Bordetella pertussis DNA in acellular pertussis vaccines. Pediatr Infect Dis J. 2008;27):73-4.
• Paddock CD, Sanden GN, Cherry JD, Gal A, Langston C, Tatti K, Wu KH, Goldsmith, C, Greer P, Montague J, Eliason M, Holman R, Guarner J, Shieh W, Zaki S. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis. 2008;47:328-38.
• Tatti K, Wu KH, Sanden G, Greer P, Sumner J, Guarner J, Paddock C, Zaki S. Molecular diagnosis of Bordetella pertussis infection by evaluation of formalin-fixed tissue specimens. J Clin Microbiol. 2006;44(3):1074-6.
• CDC. Fatal case of unsuspected pertussis diagnosed from a blood culture--Minnesota, 2003
  MMWR 2004;53(6):131-2
• Hardwick T, Cassiday P, Weyant R, Bisgard K, Sanden G. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis. 2002;8:44-9.
• Hardwick, T., Plikaytis, B., Cassiday, P., Cage, G., Peppler, M., Shea, D., Boxrud, D., & Sanden, G. Reproducibility of Bordetella pertussis genomic DNA fragments generated by Xba I restriction and resolved by pulsed-field gel electrophoresis. J Clin Microbiol. 2002;40:811-6.
• Bisgard K, Christie C, Reising S, Sanden G, Cassiday P, Gomersall C, Wattigney W, Roberts N, Strebel P. Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J Infect Dis. 2001;183:1360-7.
• Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard K, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis. 2000;182:1402-8.
• Kurzynski TA, Boehm DM, Rott-Petri J, Schell R, Allison P. Comparison of modified Bordet-Gengou and modified Regan-Lowe media for the isolation of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol. 1998;26:2661-3.
• Brennan M, Strebel P, George H, Yih W, Tachdjian R, Lett S, Cassiday P, Sanden G, Wharton M. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis. 1999;181:210-5.
• Beall B, Cassiday P, Sanden G. Analysis of Bordetella pertussis isolates from an epidemic by pulsed-field gel electrophoresis. J Clin Microbiol. 1995;33:3083-6.
• Ruijs GJ, Groenendijk TW, Biever M. Shelf life of prepared Bordet-Gengou and Regan-Lowe agar plates for isolation of Bordetella pertussis. Eur J Clin Microbiol Infect Dis. 1991;10:974-8.
• Regan J, Lowe F. Enrichment medium for the isolation of Bordetella. J Clin Microbiol. 1977;6:303-9.

Related: Diphtheria

• Tiwari T, Golaz A, Yu D, Ehresmann K, Jones T, Hill H, Cassiday P, Pawloski L, Moran J, Popovic T, Wharton M. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis. 2008;46:395-401.
• Fatal Respiratory Diphtheria in a US Traveler to Haiti---Pennsylvania, 2003
  MMWR January 9, 2004;52(53):1285-6
• Mothershed E, Cassiday P, Pierson K, Mayer L, Popovic T. Development of a real-time fluorescence PCR assay for rapid detection of the diphtheria toxin gene. J Clin Microbiol. 2002;40:4713-9.

Top of Page